Compounds > triazoles
Page last updated: 2024-08-24

triazoles and mln 8237

triazoles has been researched along with mln 8237 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Beltran, H; Demichelis, F; Rickman, DS; Rubin, MA1
Beck, A; Becker, K; Eberherr, C; Häberle, B; Kappler, R; Vokuhl, C; Von Schweinitz, D1
Lee, DG; Nguyen, R; Peng, J; Sun, M; Thiele, CJ; Wang, H1

Other Studies

3 other study(ies) available for triazoles and mln 8237

ArticleYear
Biology and evolution of poorly differentiated neuroendocrine tumors.
    Nature medicine, 2017, Jun-06, Volume: 23, Issue:6

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Azepines; Benzodiazepines; Carcinogenesis; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cell Differentiation; Cell Lineage; Cell Plasticity; Colonic Neoplasms; Disease Progression; Epigenesis, Genetic; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Neuroendocrine Tumors; Ovarian Neoplasms; Prostatic Neoplasms; Proto-Oncogene Proteins c-met; Proto-Oncogene Proteins c-myc; Pyrimidines; Retinoblastoma Binding Proteins; Triazoles; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms

2017
Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells.
    International journal of oncology, 2019, Volume: 54, Issue:5

    Topics: Adolescent; Azepines; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; DNA Methylation; Early Detection of Cancer; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Hepatoblastoma; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; N-Myc Proto-Oncogene Protein; Neoplasm Proteins; Pyrimidines; RNA, Antisense; Triazoles; Up-Regulation

2019
Combining selinexor with alisertib to target the p53 pathway in neuroblastoma.
    Neoplasia (New York, N.Y.), 2022, Volume: 26

    Topics: Animals; Apoptosis; Azepines; Cell Line, Tumor; Humans; Hydrazines; Karyopherins; Mice; Neuroblastoma; Proteomics; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Triazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2022